obesity drugs

Wegovy
Health Tech

Hims & Hers stock drops 30% after Novo Nordisk terminates deal

Hims & Hers stock plunged 30% on Monday after Novo Nordisk abruptly ended a collaboration to offer direct access to its weight loss drug Wegovy.
Heather Landi Jun 23, 2025 12:00pm
Human hands connecting puzzles

Cost Plus Drugs partners with 9amHealth on obesity care drugs

Jun 18, 2025 6:00am
Two packages of a fictitious Semaglutide drug used for weight loss

Knownwell joins Lilly Direct; Hims & Hers adds weight loss meds

Apr 3, 2025 11:30am
Semaglutide injection pen or cartridge pen for diabetics and weight loss in female hand

Primary care docs concerned about online GLP-1 prescribers

Feb 13, 2025 4:00pm
Hims Hers Super Bowl commercial

Hims & Hers' Super Bowl ad turns up the heat on GLP-1 battle

Feb 13, 2025 8:00am
vial of Zepbound obesity drug

Ro, Eli Lilly strike deal to offer lower-price vials of Zepbound

Dec 12, 2024 8:00am